Distinct changes in T cell repertoire associated with GVL and gvhd in patients receiving donor lymphocyte infusion after allogeneic bone marrow transplantation.

被引：0
|
作者：
Orsini, E [1 ]
Claret, EJ [1 ]
Alyea, EP [1 ]
Schlossman, R [1 ]
Canning, C [1 ]
Soiffer, RJ [1 ]
Anderson, KC [1 ]
Ritz, J [1 ]
机构：
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1020 / 1020
页数：1
相关论文
共 50 条
  • [1] Donor lymphocyte infusion for treatment of hematological leukemia relapse in children after allogeneic bone marrow transplantation.
    Pieczonka, A
    Wachowiak, J
    Boruczkowski, D
    Leda, M
    Jólkowska, J
    Ladoñ, D
    Witt, M
    BONE MARROW TRANSPLANTATION, 2002, 30 : S63 - S63
  • [2] Membranous Nephropathy Associated with Donor Lymphocyte Infusion following Allogeneic Bone Marrow Transplantation
    Yasuhiko Miyazaki
    Yasukiyo Mori
    Noriko Kishimoto
    Noriaki Matsumoto
    Katsuhiro Zen
    Ryuichi Amakawa
    Yuji Kishimoto
    Shirou Fukuhara
    International Journal of Hematology, 2003, 78 : 262 - 265
  • [3] Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation
    Miyazaki, Y
    Mori, Y
    Kishimoto, N
    Matsumoto, N
    Zen, K
    Amakawa, R
    Kishimoto, Y
    Fukuhara, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (03) : 262 - 265
  • [4] Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GvHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion
    Nakamura, K
    Inaba, M
    Sugiura, K
    Yoshimura, T
    Kwon, AH
    Kamiyama, Y
    Ikehara, S
    STEM CELLS, 2004, 22 (02) : 125 - 134
  • [5] Combination chemotherapy and donor lymphocyte infusion for treatment of aggressive hematologic malignancies in relapse after allogeneic bone marrow transplantation.
    Mookerjee, B
    Couzi, R
    Seber, A
    Miller, C
    Noga, S
    Douglas, T
    Altomonte, V
    Gore, S
    Jones, R
    Vogelsang, G
    Fuchs, E
    CLINICAL CANCER RESEARCH, 1999, 5 : 3734S - 3734S
  • [6] Donor lymphocyte infusion - Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphoma
    Lee, CK
    de Magalhaes-Silverman, M
    Hohl, RJ
    Hayashi, M
    Buatti, J
    Wen, BC
    Schlueter, A
    Strauss, RG
    Gingrich, RD
    BONE MARROW TRANSPLANTATION, 2002, 29 (07) : 615 - 620
  • [7] Tumor-specific Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation.
    Tawara, Isao
    Katayama, Naoyuki
    Shiku, Hiroshi
    Ikeda, Hiroaki
    CANCER SCIENCE, 2018, 109 : 757 - 757
  • [8] Adoptive immunotherapy with donor lymphocyte infusion after allogeneic nonmyeloablative stem cell transplantation.
    Qiao, ZH
    Zheng, ZZ
    Ye, F
    Ma, LM
    Gong, R
    BLOOD, 2005, 106 (11) : 383B - 383B
  • [9] Association of higher total nucleated cell dose with improved survival in patients receiving donor lymphocyte infusion after allogeneic stem cell transplantation.
    Singh, Nathan
    Kumar, Anita J.
    Gao, Amy
    Luskin, Marlise Rachael
    Frey, Noelle V.
    Hexner, Elizabeth O.
    Loren, Alison W.
    Luger, Selina M.
    Stadtmauer, Edward Allen
    Porter, David L.
    Reshef, Ran
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] A metalloproteinase inhibitor prevents acute GVHD while preserving GVL effect of allogeneic bone marrow transplantation.
    Hattori, K
    Hirano, T
    Tateno, M
    Oshimi, K
    Kayagaki, N
    Yagita, H
    Okumura, K
    BLOOD, 1998, 92 (10) : 292B - 292B
12345